Simplex Trading, LLC Novo Cure LTD Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$12.42 - $17.29 $336,892 - $468,991	-27,125 Reduced 48.34%	28,986 $453,000
Q4 2023 Feb 02, 2024	BUY	$11.13 - $15.78 $624,515 - $885,431	56,111 New	56,111 $837,000
Q2 2023 Aug 04, 2023	BUY	$40.29 - $82.51 $446,171 - $913,715	11,074 Added 11074.0%	11,174 $463,000
Q1 2023 Apr 27, 2023	SELL	$56.44 - $118.81 $16,819 - $35,405	-298 Reduced 74.87%	100 $6,000
Q4 2022 Feb 02, 2023	BUY	$63.98 - $85.37 $12,796 - $17,074	200 Added 101.01%	398 $29,000
Q3 2022 Nov 04, 2022	SELL	$67.99 - $89.57 $93,146 - $122,710	-1,370 Reduced 87.37%	198 $15,000
Q2 2022 Aug 03, 2022	SELL	$56.6 - $89.9 $347,354 - $551,716	-6,137 Reduced 79.65%	1,568 $108,000
Q1 2022 May 02, 2022	SELL	$60.15 - $84.52 $186,585 - $262,181	-3,102 Reduced 28.7%	7,705 $638,000
Q4 2021 Feb 23, 2022	BUY	$75.08 - $121.99 $110,743 - $179,935	1,475 Added 15.81%	10,807 $811,000
Q3 2021 Oct 28, 2021	SELL	$116.17 - $194.55 $164,496 - $275,482	-1,416 Reduced 13.17%	9,332 $1.77 Million
Q2 2021 Aug 12, 2021	BUY	$130.4 - $225.58 $324,435 - $561,243	2,488 Added 30.12%	10,748 $2.38 Million
Q1 2021 Apr 26, 2021	BUY	$124.11 - $190.17 $992,135 - $1.52 Million	7,994 Added 3005.26%	8,260 $1.09 Million
Q3 2020 Oct 14, 2020	SELL	$58.05 - $111.31 $552,926 - $1.06 Million	-9,525 Reduced 97.28%	266 $29,000
Q2 2020 Jul 13, 2020	BUY	$57.2 - $74.41 $548,605 - $713,666	9,591 Added 4795.5%	9,791 $580,000
Q1 2020 Apr 29, 2020	BUY	$57.05 - $95.75 $11,410 - $19,150	200 New	200 $13,000
Q4 2019 Feb 05, 2020	SELL	$68.3 - $93.8 $968,289 - $1.33 Million	-14,177 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$61.86 - $97.8 $253,007 - $400,002	-4,090 Reduced 22.39%	14,177 $1.06 Million
Q2 2019 Jul 26, 2019	BUY	$42.22 - $63.23 $771,232 - $1.16 Million	18,267 New	18,267 $1.16 Million
Q1 2019 Apr 18, 2019	SELL	$31.96 - $56.12 $231,486 - $406,477	-7,243 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$28.72 - $52.63 $17,203 - $31,525	-599 Reduced 7.64%	7,243 $242,000
Q3 2018 Oct 23, 2018	BUY	$32.0 - $52.4 $237,088 - $388,231	7,409 Added 1711.09%	7,842 $410,000
Q2 2018 Jul 30, 2018	BUY	$19.85 - $32.0 $8,595 - $13,856	433 New	433 $13,000
Q1 2018 Apr 26, 2018	SELL	$19.3 - $23.65 $118,347 - $145,021	-6,132 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$16.3 - $21.9 $57,587 - $77,372	3,533 Added 135.94%	6,132 $123,000
Q3 2017 Oct 25, 2017	BUY	$18.05 - $21.75 $46,911 - $56,528	2,599	2,599 $51,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

76.9M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$319 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$312 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$209 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$113 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$79.8 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account